Comparing Thoracolumbar Interfascial and Quadro Iliac Plane Blocks on Postoperative Opioid Use Following Lumbar Microsurgery
Launched by MEDIPOL UNIVERSITY · Feb 24, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to manage pain after a common back surgery called lumbar microdiscectomy, which is often done to treat herniated discs. Researchers want to see how well two types of nerve blocks, the Thoracolumbar Interfascial Plane (TLIP) block and the Quadro Iliac Plane block, can help reduce the need for opioid pain medications after surgery. Opioids can be effective for pain relief but may cause unwanted side effects like nausea, difficulty breathing, and dependency. By comparing these two methods, the study aims to determine which one leads to less opioid use and fewer side effects.
To participate in this trial, individuals should be between the ages of 18 and 80 and scheduled for lumbar microdiscectomy surgery. They should be in good health overall, classified as ASA physical status I to III, which means they have no serious health issues. However, people with certain allergies, those who are pregnant, or anyone with significant mental health or neurological conditions cannot join the study. Participants will receive either of the two nerve blocks before their surgery and will be monitored afterward for pain levels and any side effects, helping to improve pain management practices for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged 18 to 80 years
- • American Society of Anesthesiologists (ASA) physical status I to III
- • scheduled for lumbar microdiscectomy surgery
- Exclusion Criteria:
- • Known allergy to local anesthetics
- • Any other significant drug allergies related to the study interventions
- • Pregnancy
- • Pre-existing psychiatric or neurological disorders
- • Inability to provide informed consent
About Medipol University
Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported